UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056201
Receipt number R000057804
Scientific Title Home-based exercise for cancer patients with chemotherapy-induced peripheral neuropathy-Feasibility Study-
Date of disclosure of the study information 2024/11/19
Last modified on 2025/11/28 01:16:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Home-based exercise for cancer patients with chemotherapy-induced peripheral neuropathy-Feasibility Study-

Acronym

Home-based exercise for CIPN

Scientific Title

Home-based exercise for cancer patients with chemotherapy-induced peripheral neuropathy-Feasibility Study-

Scientific Title:Acronym

Home-based exercise for CIPN-Feasibility Study-

Region

Japan


Condition

Condition

Chemotherapy-induced peripheral neuropathy

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Chemotherapy-induced peripheral neuropathy is a frequent adverse event, but there is no established treatment method yet. This study examines the tolerability of home-based exercise therapy in cancer patients with chemotherapy-induced peripheral neuropathy.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of participation in outpatient rehabilitation sessions by physical therapists and occupational therapists

Key secondary outcomes

Home exercise status
Physical function
sensory function
ADL
manual dexterity
QOL
Chemotherapy Compliance


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cancer patients undergoing outpatient treatment at National Hospital Organization Tokyo Medical Center.
Patients 20 years of age or older who have visited the outpatient clinic for rehabilitation for chemotherapy-induced peripheral neuropathy.
Patients who are able to undergo physical function assessment.
Patients who have given consent to participate in the study.

Key exclusion criteria

Patients with communication difficulties, such as inability to understand the purpose of the study
Patients with pre-existing or coexisting cerebrospinal and psychiatric disorders
Patients who received only speech therapy
Patients with reasons deemed inappropriate by the physician in charge

Target sample size

25


Research contact person

Name of lead principal investigator

1st name CHIEKO
Middle name
Last name MIYATA

Organization

NHO Tokyo Medical Center

Division name

Palliative care and cancer rehabilitation

Zip code

152-8902

Address

Meguro-ku, Higashigaoka2-5-1, Tokyo

TEL

03-3411-0111

Email

kuma1mie2chibi3@hosp.go.jp


Public contact

Name of contact person

1st name CHIEKO
Middle name
Last name MIYATA

Organization

NHO Tokyo Medical Center

Division name

Palliative care and cancer rehabilitation

Zip code

152-8902

Address

Meguro-ku, Higashigaoka2-5-1, Tokyo

TEL

03-3411-0111

Homepage URL


Email

kuma1mie2chibi3@yahoo.co.jp


Sponsor or person

Institute

NHO Tokyo Medical Center

Institute

Department

Personal name

Chieko Miyata


Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Tokyo Medical Center

Address

Meguro-ku, Higashigaoka2-5-1, Tokyo

Tel

03-3411-0111

Email

rinrijm@hosp.ncgm.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 19 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

DOI: https://www.doi.org/10.1186/s13102-025-01223-1

Number of participants that the trial has enrolled

25

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2025 Year 07 Month 02 Day

Baseline Characteristics


Participant flow


Adverse events

No adverse events directly attributable to the rehabilitation were observed.

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 03 Month 30 Day

Date of IRB

2022 Year 04 Month 14 Day

Anticipated trial start date

2022 Year 12 Month 20 Day

Last follow-up date

2024 Year 12 Month 28 Day

Date of closure to data entry

2025 Year 01 Month 10 Day

Date trial data considered complete

2025 Year 01 Month 10 Day

Date analysis concluded

2025 Year 01 Month 15 Day


Other

Other related information

Study design: prospective cohort study. Methods of recruitment: patients who visited our institution between December 2022 and February 2024 and met the selection criteria. Primary endpoints: percentage of participation in outpatient rehabilitation sessions, drop-out rate from rehabilitation. Secondary endpoints: physical function, activities of daily living, quality of life and cancer treatment compliance.


Management information

Registered date

2024 Year 11 Month 19 Day

Last modified on

2025 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057804